We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.
- Authors
Merli, G; Spiro, T E; Olsson, C G; Abildgaard, U; Davidson, B L; Eldor, A; Elias, D; Grigg, A; Musset, D; Rodgers, G M; Trowbridge, A A; Yusen, R D; Zawilska, K; Enoxaparin Clinical Trial Group
- Abstract
Low-molecular-weight heparins administered subcutaneously once or twice daily have been reported to be as safe and efficacious as intravenous unfractionated heparin in the treatment of acute venous thromboembolic disease.
- Publication
Annals of internal medicine, 2001, Vol 134, Issue 3, p191
- ISSN
0003-4819
- Publication type
Journal Article
- DOI
10.7326/0003-4819-134-3-200102060-00009